OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antigen‐specific mRNA lipid nanoparticle platforms for the prevention and treatment of allergy and autoimmune diseases
Emma Y. Yim, Amanda C. Zhou, Yvonne C. Yim, et al.
BMEMat (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 14
Emma Y. Yim, Amanda C. Zhou, Yvonne C. Yim, et al.
BMEMat (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 14
Showing 14 citing articles:
Orally Deliverable Sequence-Targeted Fucoxanthin-Loaded Biomimetic Extracellular Vesicles for Alleviation of Nonalcoholic Fatty Liver Disease
Caiyun Wu, Siyuan Xiang, Haitao Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9854-9867
Closed Access | Times Cited: 13
Caiyun Wu, Siyuan Xiang, Haitao Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 8, pp. 9854-9867
Closed Access | Times Cited: 13
An overview of lipid constituents in lipid nanoparticle mRNA delivery systems
Shiqi Wu, Lixin Lin, Lu Shi, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 8
Shiqi Wu, Lixin Lin, Lu Shi, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 8
Discovery of Ketal‐Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery
Kai Lv, Zhenlei Yu, Jing Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Kai Lv, Zhenlei Yu, Jing Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Biomaterials Functionalized with Inflammasome Inhibitors—Premises and Perspectives
Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 2, pp. 32-32
Open Access | Times Cited: 4
Norina Vinţeler, Claudia Nicoleta Feurdean, Regina Petkes, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 2, pp. 32-32
Open Access | Times Cited: 4
Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Tolerogenic nanovaccines for the treatment of type I allergic diseases
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access
Delivery of Itgb1-siRNA by triptolide-modified and anti-Flt1 peptide-guided ionizable cationic LNPs for targeted therapy of corneal neovascularization
Yuwen Song, Tingting Xu, Hao Li, et al.
Journal of Controlled Release (2025), pp. 113811-113811
Closed Access
Yuwen Song, Tingting Xu, Hao Li, et al.
Journal of Controlled Release (2025), pp. 113811-113811
Closed Access
Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance
Sydney Kusumoputro, Christian Au, Katie H. Lam, et al.
Nanomaterials (2023) Vol. 14, Iss. 1, pp. 67-67
Open Access | Times Cited: 10
Sydney Kusumoputro, Christian Au, Katie H. Lam, et al.
Nanomaterials (2023) Vol. 14, Iss. 1, pp. 67-67
Open Access | Times Cited: 10
Inflammation-Responsive Polyion Complex Vesicles for Autoimmune Disease Therapy via Cell-Free DNA Scavenging and Inflammatory Microenvironment Modulation
Renxiang Zhou, Yang Zhou, Mengyuan Yin, et al.
ACS Nano (2024) Vol. 18, Iss. 43, pp. 30017-30030
Closed Access | Times Cited: 3
Renxiang Zhou, Yang Zhou, Mengyuan Yin, et al.
ACS Nano (2024) Vol. 18, Iss. 43, pp. 30017-30030
Closed Access | Times Cited: 3
Interaction design in mRNA delivery systems
Mengyao Yu, Lixin Lin, Dezhong Zhou, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 413-426
Closed Access | Times Cited: 2
Mengyao Yu, Lixin Lin, Dezhong Zhou, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 413-426
Closed Access | Times Cited: 2
In vivo Delivery Processes and Development Strategies of Lipid Nanoparticles
Jiashun Cheng, Lina Jian, Zhaolin Chen, et al.
ChemBioChem (2024)
Closed Access | Times Cited: 1
Jiashun Cheng, Lina Jian, Zhaolin Chen, et al.
ChemBioChem (2024)
Closed Access | Times Cited: 1
Advancing Cancer Vaccines with Radionuclide Imaging
Sixuan Cheng, Xingbo Long, Yongxue Zhang, et al.
Small (2024)
Closed Access | Times Cited: 1
Sixuan Cheng, Xingbo Long, Yongxue Zhang, et al.
Small (2024)
Closed Access | Times Cited: 1
Rational Design of Lipid-Based Vectors for Advanced Therapeutic Vaccines
Yufei Ma, Yiang Chen, Zilu Li, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 603-603
Open Access
Yufei Ma, Yiang Chen, Zilu Li, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 603-603
Open Access
Unleashing the potential of mRNA : Overcoming delivery challenges with nanoparticles
Qiang Chen, Ku‐Geng Huo, Sheng‐Min Ji, et al.
Bioengineering & Translational Medicine (2024)
Open Access
Qiang Chen, Ku‐Geng Huo, Sheng‐Min Ji, et al.
Bioengineering & Translational Medicine (2024)
Open Access
Microfluidic Nanoparticle Separation for Precision Medicine
Zhenwei Lan, Rui Chen, Da Zou, et al.
Advanced Science (2024)
Closed Access
Zhenwei Lan, Rui Chen, Da Zou, et al.
Advanced Science (2024)
Closed Access
